Carisma Therapeutics, Inc. Stock
Stocks
CARM
US14216R1014
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
14:15:38 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 0.000700 USD | 0.00% |
|
-46.15% | -98.37% |
| Market Cap | 1.8M 1.55M 1.46M 1.33M 2.48M 171M 2.49M 17.25M 6.67M 87.2M 6.76M 6.61M 277M | P/E 2023 |
-1.13x | P/E 2024 | -0.29x |
|---|---|---|---|---|---|
| Enterprise Value | -14.55M -12.52M -11.78M -10.75M -20.06M -1.38B -20.16M -139M -53.94M -705M -54.65M -53.45M -2.24B | EV / Sales 2023 |
2,933,403x | EV / Sales 2024 | 57,658x |
| Free-Float |
76.96% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 week | -46.15% | ||
| Current month | -46.15% | ||
| 1 month | -72.00% | ||
| 3 months | +600.00% | ||
| 6 months | -98.31% | ||
| Current year | -98.37% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.43 |
| 3 years | 0 | | 5.22 |
| 5 years | 0 | | 9.77 |
| 10 years | 0 | | 9.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 65 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
BRD | Director/Board Member | 65 | 2025-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/7/25 | Exercice | Founder | 170,946 | 0.4095% | ||
| 10/1/25 | Sell | Founder | 484,347 | 1.1601% | ||
| 1/28/25 | Free | Chief Executive Officer | 500,000 | 1.1976% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -46.15% | -99.83% | -99.99% | 29.29K | |
| +2.02% | +1.01% | +45.58% | +104.91% | 67.82B | |
| -0.41% | -1.12% | +35.32% | +80.68% | 63.22B | |
| -1.11% | +2.52% | -13.93% | +369.69% | 27.58B | |
| -4.92% | -2.90% | -12.27% | -17.60% | 26.06B | |
| +1.69% | +0.94% | +33.46% | +17.80% | 25.38B | |
| +1.12% | +2.03% | +23.61% | -17.59% | 19.89B | |
| +6.04% | +0.72% | +239.13% | +407.95% | 17.4B | |
| -0.49% | -1.85% | -6.87% | +546.36% | 14.95B | |
| -2.27% | +5.55% | +52.24% | +161.90% | 14.62B | |
| Average | +0.72% | -2.36% | +29.64% | +155.41% | 27.69B | |
| Weighted average by Cap. | +0.82% | +1.55% | +38.86% | +143.32% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 14.92 12.83 12.07 11.02 20.56 1.41K 20.67 143 55.3 723.02 56.02 54.79 2.29K | 19.63 16.89 15.89 14.5 27.06 1.86K 27.2 188.17 72.77 951.43 73.72 72.1 3.02K |
| Net income | -86.88M -74.73M -70.31M -64.16M -120M -8.24B -120M -833M -322M -4.21B -326M -319M -13.35B | -60.48M -52.02M -48.94M -44.66M -83.35M -5.73B -83.78M -580M -224M -2.93B -227M -222M -9.29B |
| Net Debt | -74.48M -64.07M -60.28M -55.01M -103M -7.06B -103M -714M -276M -3.61B -280M -274M -11.45B | -16.35M -14.07M -13.23M -12.08M -22.54M -1.55B -22.65M -157M -60.61M -793M -61.41M -60.06M -2.51B |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-08 | US$0.000700 | 0.00% | 2,241 |
| 26-09-04 | US$0.000700 | -22.22% | 992 |
| 26-09-03 | US$0.000900 | +28.57% | 16,567 |
| 26-09-02 | US$0.000700 | -30.00% | 6,207 |
| 26-09-01 | US$0.001000 | -23.08% | 7,746 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CARM Stock
Select your edition
All financial news and data tailored to specific country editions
